Rlx Tech Spadr1 Stock Fundamentals
| 3CM Stock | EUR 1.76 0.10 5.38% |
RLX TECH SPADR1 fundamentals help investors to digest information that contributes to RLX TECH's financial success or failures. It also enables traders to predict the movement of RLX Stock. The fundamental analysis module provides a way to measure RLX TECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RLX TECH stock.
RLX |
RLX TECH SPADR1 Company Shares Outstanding Analysis
RLX TECH's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current RLX TECH Shares Outstanding | 1.55 B |
Most of RLX TECH's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RLX TECH SPADR1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, RLX TECH SPADR1 has 1.55 B of shares currently outstending. This is much higher than that of the Technology sector and significantly higher than that of the Health Information Services industry. The shares outstanding for all Germany stocks is 170.7% lower than that of the firm.
RLX TECH SPADR1 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RLX TECH's current stock value. Our valuation model uses many indicators to compare RLX TECH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RLX TECH competition to find correlations between indicators driving RLX TECH's intrinsic value. More Info.RLX TECH SPADR1 is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for RLX TECH SPADR1 is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RLX TECH's earnings, one of the primary drivers of an investment's value.RLX Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RLX TECH's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RLX TECH could also be used in its relative valuation, which is a method of valuing RLX TECH by comparing valuation metrics of similar companies.RLX TECH is number one stock in shares outstanding category among its peers.
RLX Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0782 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.30 % | |||
| Shares Outstanding | 1.55 B | |||
| Shares Owned By Insiders | 39.33 % | |||
| Shares Owned By Institutions | 29.41 % | |||
| Revenue | 6.9 B | |||
| Gross Profit | 3.67 B | |||
| EBITDA | 2.13 B | |||
| Current Ratio | 15.81 X | |||
| Book Value Per Share | 11.76 X | |||
| Earnings Per Share | 0.21 X | |||
| Target Price | 4.23 | |||
| Number Of Employees | 1.24 K | |||
| Beta | 0.41 | |||
| Market Capitalization | 3.17 B |
About RLX TECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RLX TECH SPADR1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RLX TECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RLX TECH SPADR1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cannvas MedTech Inc. operates as a business technology company within the health sciences sector in the United States and internationally. Cannvas MedTech Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada. CANNVAS MEDTECH is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in RLX Stock
RLX TECH financial ratios help investors to determine whether RLX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RLX with respect to the benefits of owning RLX TECH security.